Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Long-QT syndromes are heritable diseases associated with prolongation of the QT interval on an electrocardiogram and a high risk of sudden cardiac death due to ventricular tachyarrhythmia. In long-QT syndrome type 1, mutations occur in the KCNQ1 gene, which encodes the repolarizing potassium channel mediating the delayed rectifier I(Ks) current. METHODS: We screened a family affected by long-QT syndrome type 1 and identified an autosomal dominant missense mutation (R190Q) in the KCNQ1 gene. We obtained dermal fibroblasts from two family members and two healthy controls and infected them with retroviral vectors encoding the human transcription factors OCT3/4, SOX2, KLF4, and c-MYC to generate pluripotent stem cells. With the use of a specific protocol, these cells were then directed to differentiate into cardiac myocytes. RESULTS: Induced pluripotent stem cells maintained the disease genotype of long-QT syndrome type 1 and generated functional myocytes. Individual cells showed a “ventricular,” “atrial,” or “nodal” phenotype, as evidenced by the expression of cell-type–specific markers and as seen in recordings of the action potentials in single cells. The duration of the action potential was markedly prolonged in “ventricular” and “atrial” cells derived from patients with long-QT syndrome type 1, as compared with cells from control subjects. Further characterization of the role of the R190Q–KCNQ1 mutation in the pathogenesis of long-QT syndrome type 1 revealed a dominant negative trafficking defect associated with a 70 to 80% reduction in I(Ks) current and altered channel activation and deactivation properties. Moreover, we showed that myocytes derived from patients with long-QT syndrome type 1 had an increased susceptibility to catecholamine-induced tachyarrhythmia and that beta-blockade attenuated this phenotype. CONCLUSIONS: We generated patient-specific pluripotent stem cells from members of a family affected by long-QT syndrome type 1 and induced them to differentiate into functional cardiac myocytes. The patient-derived cells recapitulated the electrophysiological features of the disorder. (Funded by the European Research Council and others.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ventricle beat rates showed a positive chronotropic response over the concentration range in both the NRVM and hiPSC-CM ventricles (Fig. 3c), as expected for healthy NRVM59, hiPSC-CM60, engineered hiPSC-CM cardiac tissues16, and human patients61.”
From A tissue-engineered scale model of the heart ventricle (2018) · cites this paper as [60]
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Previous studies using iPSC-derived cardiomyocytes from type-1 LQTS patients revealed that the mutation in KCNQ1 caused potassium ion channel dysfunction resulting in sarcolemmal deficiency [5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Tumorous cell lines, although able to proliferate, are often incorporated with unwanted genetic or chromosomal abnormalities, which might induce interference to the resulting outcomes [4,5].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Models built with iPSC derivatives also demonstrate functional and phenotypic traits comparable to their human in vivo parallel [4,5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549
Risk Stratification in the Long-QT Syndrome
Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,459
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming
Jaenisch, R., & Young, R. (2008) · Cell · doi:10.1016/j.cell.2008.01.015 · Cited by 1,427
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Research works printed but not linked: 2
- Freund C, 2010, Neth Heart J, 18, 51
- Brunner M, 2008, J Clin Invest, 118, 2246
Cited by
Items 501–600 of 1,000
Bagheri‐Mohammadi, S., Karimian, M., Alani, B., Verdi, J., Tehrani, R. M., & Noureddini, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27182 · Cited by 28
Li, Y., Lang, S., Akin, I., Zhou, X., & El‐Battrawy, I. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024410 · Cited by 29
Budniatzky, I., & Gepstein, L. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0163 · Cited by 32
Tracking gene and cell fate for therapeutic gain
Kooreman, N. G., Ransohoff, J. D., & Wu, J. C. (2014) · Nature Materials · doi:10.1038/nmat3868 · Cited by 28
Generation of Patient-Specific Induced Neuronal Cells Using a Direct Reprogramming Strategy
Wang, P., Zhang, H. L., Li, W., Sha, H., Xu, C., Yao, L., Tang, Q., Tang, H., Chen, L., & Zhu, J. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0131 · Cited by 28
Trevisan, M., Sinigaglia, A., Desole, G., Berto, A., Pacenti, M., Palù, G., & Barzon, L. (2015) · Viruses · doi:10.3390/v7072800 · Cited by 28
Urine as a Source of Stem Cells
Benda, C., Zhou, T., Wang, X., Tian, W., Grillari, J., Tse, H., Grillari‐Voglauer, R., Pei, D., & Esteban, M. A. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_157 · Cited by 30
Engineered Human Cardiac Tissue
Kreutziger, K. L., & Murry, C. E. (2011) · Pediatric Cardiology · doi:10.1007/s00246-011-9888-9 · Cited by 32
Sander, P., Feng, M. S.-F., Schweitzer, M. K., Wilting, F., Gutenthaler, S. M., Arduíno, D. M., Fischbach, S., Dreizehnter, L., Moretti, A., Gudermann, T. W., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15630 · Cited by 27
Self-citationNarkar, A., Willard, J. M., & Blinova, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063199 · Cited by 33
Modeling Long-QT Syndromes with iPS Cells
Sinnecker, D., Goedel, A., Dorn, T., Dirschinger, R. J., Moretti, A., & Laugwitz, K. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9416-1 · Cited by 27
Self-citationhiPSC Modeling of Inherited Cardiomyopathies
Jung, G., & Bernstein, D. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0320-7 · Cited by 28
Human Kidney Cell Reprogramming: Applications for Disease Modeling and Personalized Medicine
O’Neill, A. C., & Ricardo, S. D. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012121199 · Cited by 29
Trantidou, T., Terracciano, C. M., Kontziampasis, D., Humphrey, E. J., & Prodromakis, T. (2015) · Scientific Reports · doi:10.1038/srep11067 · Cited by 28
Kuusela, J., Kujala, V. J., Kiviaho, A., Ojala, M., Swan, H., KONTULA, K. K., & Aalto‐Setälä, K. (2016) · SpringerPlus · doi:10.1186/s40064-016-1889-y · Cited by 27
The Brain-Heart Connection in Sympathetically Triggered Inherited Arrhythmia Syndromes
Winbo, A., & Paterson, D. J. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.11.002 · Cited by 27
Cell reprogramming: methods, mechanisms and applications
Zhu, F., & Nie, G. (2025) · Cell Regeneration · doi:10.1186/s13619-025-00229-x · Cited by 27
Yamakawa, H., & Ieda, M. (2015) · International Heart Journal · doi:10.1536/ihj.14-344 · Cited by 26
Phenotypic assays for analyses of pluripotent stem cell–derived cardiomyocytes
Pešl, M., Přibyl, J., Caluori, G., Čmiel, V., Aćimović, I., Jelínková, Š., Dvořák, P., Stárek, Z., Skládal, P., & Rotrekl, V. (2016) · Journal of Molecular Recognition · doi:10.1002/jmr.2602 · Cited by 27
Kempf, H., & Zweigerdt, R. (2017) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2017_30 · Cited by 29
Chromosomal aberrations after induced pluripotent stem cells reprogramming
Vaz, I. M., Borgonovo, T., Kasai-Brunswick, T. H., dos Santos, D. S., Mesquita, F., Vasques, J. F., Gubert, F., Rebelatto, C. L. K., Senegaglia, A. C., & Brofman, P. R. S. (2021) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2020-0147 · Cited by 26
From Pluripotency to Distinct Cardiomyocyte Subtypes
David, R., & Franz, W. (2012) · Physiology · doi:10.1152/physiol.00044.2011 · Cited by 29
Stem cell-based strategies for the treatment of type 1 diabetes mellitus
Wen, Y., Chen, B., & Ildstad, S. T. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.540235 · Cited by 28
Nuclear Reprogramming Strategy Modulates Differentiation Potential of Induced Pluripotent Stem Cells
Martinez‐Fernandez, A., Nelson, T. J., & Terzic, A. (2011) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9250-2 · Cited by 31
Lahm, H., Doppler, S. A., Dreßen, M., Werner, A., Adamczyk, K., Schrambke, D., Brade, T., Laugwitz, K., Deutsch, M.-A., Schiemann, M., et al. (2014) · Stem Cells · doi:10.1002/stem.1872 · Cited by 33
Self-citationVaskova, E. A., Medvedev, S. P., Sorokina, A. E., Nemudryi, A. A., Elisaphenko, E. A., Zakharova, I. S., Shevchenko, A. I., Kizilova, E. A., Zhelezova, A. I., Evshin, I. S., et al. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0204 · Cited by 26
Human Stem Cell-Derived Cardiac Model of Chronic Drug Exposure
Nunes, S. S., Feric, N. T., Pahnke, A., Miklas, J. W., Li, M., Coles, J. G., Gagliardi, M., Keller, G. M., & Radisic, M. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00496 · Cited by 28
Duncan, G., Firth, K., George, V. T., Hoang, M. D., Staniforth, A., Smith, G. L., & Denning, C. N. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0172 · Cited by 29
Mechanisms underlying epilepsies associated with sodium channel mutations
Steinlein, O. K. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63326-2.00005-3 · Cited by 28
Advancing Cardiovascular Research
Lauer, M. S. (2012) · CHEST Journal · doi:10.1378/chest.11-2521 · Cited by 29
Induced pluripotent stem cells as a next-generation biomedical interface
Hankowski, K. E., Hamazaki, T., Umezawa, A., & Terada, N. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.85 · Cited by 30
Romano, G., Morales, F., Marino, I. R., & Giordano, A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24437 · Cited by 26
Regenerative medicine for the treatment of heart disease
Hansson, E. M., & Lendahl, U. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12033 · Cited by 29
Kikuchi, C., Bienengraeber, M., Canfield, S. G., Koopmeiner, A., Schäfer, R., Bosnjak, Z. J., & Bai, X. (2015) · Cell Transplantation · doi:10.3727/096368914x685762 · Cited by 26
Will iPSC-cardiomyocytes revolutionize the discovery of drugs for heart disease?
Bruyneel, A. A. N., McKeithan, W. L., Feyen, D. A. M., & Mercola, M. A. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.07.003 · Cited by 27
Arrhythmia Mechanisms in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
Paci, M., Penttinen, K., Pekkanen-Mattila, M., & Koivumäki, J. T. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000972 · Cited by 26
Recent Advances in CRISPR/Cas9-Based Genome Editing Tools for Cardiac Diseases
Schreurs, J., Sacchetto, C., Colpaert, R. M. W., Vitiello, L., Rampazzo, A., & Calore, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010985 · Cited by 26
Reilly, L., Munawar, S., Zhang, J., Crone, W. C., & Eckhardt, L. L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.966094 · Cited by 27
Li, N., Edel, M. J., Liu, K., Denning, C. N., Betts, J., Neely, O. C., Li, D., & Paterson, D. J. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0173 · Cited by 26
Su, S., Zhang, Y., Li, W., Xi, Y. T., Lu, Y., Shen, J., Ma, Y., Wang, Y., Shen, Y., Xie, L., et al. (2023) · Research · doi:10.34133/research.0165 · Cited by 39
Developmental neurotoxicity screening using human embryonic stem cells
Bosnjak, Z. J. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.023 · Cited by 25
A Comparison of Stem Cells for Therapeutic Use
Rodgerson, D. O., & Harris, A. G. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9241-y · Cited by 28
Integrated Analysis of Drug-Induced Gene Expression Profiles Predicts Novel hERG Inhibitors
Babcock, J. J., Du, F., Xu, K., Wheelan, S. J., & Li, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069513 · Cited by 28
Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Bezzerides, V. J., Zhang, D., & Pu, W. T. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-1113 · Cited by 26
Hansen, K. J., Favreau, J. T., Gershlak, J. R., Laflamme, M. A., Albrecht, D. R., & Gaudette, G. R. (2017) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2017.0190 · Cited by 29
The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing
Ye, L., Ni, X., Zhao, Z., Lei, W., & Hu, S. (2018) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-018-9811-3 · Cited by 27
Ruwald, M. H., Parks, X. X., Moss, A. J., Zaręba, W., Baman, J. R., McNitt, S. A., Kanters, J. K., Shimizu, W., Wilde, A. A. M., Jøns, C., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.08.033 · Cited by 24
Seki, T., Yuasa, S., Kusumoto, D., Kunitomi, A., Saito, Y., Tohyama, S., Yae, K., Kishino, Y., Okada, M., Hashimoto, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085645 · Cited by 24
New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models
Sharma, A. K., Singh, S., Bhat, M., Gill, K., Zaid, M., Kumar, S., Shakya, A., Tantray, J., Jose, D., Gupta, R., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-41942-4 · Cited by 26
Induced pluripotent stem cells in research and therapy.
Teoh, H.-K., & Cheong, S. (2012) · PubMed · Cited by 29
Harmer, S. C., Mohal, J. S., Royal, A. A., McKenna, W. J., Lambiase, P. D., & Tinker, A. (2014) · Biochemical Journal · doi:10.1042/bj20140425 · Cited by 24
Zhi, D., Irvin, M. R., Gu, C. C., Stoddard, A. J., Lorier, R., Matter, A. M., Rao, D. C., Srinivasasainagendra, V., Tiwari, H. K., Turner, A., et al. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00092 · Cited by 25
Ban, K., Wile, B. M., Cho, K.-W., Kim, S., Song, M.-K., Kim, S. Y., Singer, J., Syed, A., Yu, S. P., Wagner, M. B., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.10.021 · Cited by 24
Moreau, A., Mercier, A., Thériault, O., Boutjdir, M., Burger, B., Keller, D. I., & Chahine, M. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.10.001 · Cited by 26
Christidi, E., Huang, H., & Brunham, L. R. (2018) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2018.06.002 · Cited by 26
Experimental Models of Cardiovascular Diseases: Overview
Oh, J. G., & Ishikawa, K. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8597-5_1 · Cited by 24
Lodrini, A. M., Barile, L., Rocchetti, M., & Altomare, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020507 · Cited by 28
Harnessing the Potential of Stem Cells for Disease Modeling: Progress and Promises
Argentati, C., Tortorella, I., Bazzucchi, M., Morena, F., & Martino, S. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10010008 · Cited by 25
In Vitro Uses of Human Pluripotent Stem Cell-Derived Cardiomyocytes
Matsa, E., & Denning, C. N. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9376-5 · Cited by 26
Modeling heart disease in a dish: From somatic cells to disease-relevant cardiomyocytes
Zanella, F., Lyon, R. C., & Sheikh, F. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.06.002 · Cited by 25
Kuehle, J., Turan, S., Cantz, T., Hoffmann, D., Suerth, J. D., Maetzig, T., Zychlinski, D., Klein, C., Steinemann, D., Baum, C., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.4 · Cited by 23
Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid Cells
Jiang, G., Herron, T. J., Bernardo, J. D., Walker, K. A., O'Shea, K. S., & Kunisaki, S. M. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0016 · Cited by 23
Ryall, K. A., & Saucerman, J. J. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.04.016 · Cited by 23
Song, M., Paul, S., Lim, H., Dayem, A. A., & Cho, S. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0205-9 · Cited by 23
de Peppo, G. M., & Marolt, D. (2012) · Journal of Blood Transfusion · doi:10.1155/2012/317632 · Cited by 26
Human induced pluripotent stem cell for modeling cardiovascular diseases
Liang, P., & Du, J. (2014) · Regenerative Medicine Research · doi:10.1186/2050-490x-2-4 · Cited by 28
Rigorous Phenotyping of Cardiac iPSC Preparations Requires Knowledge of Their Resting Potential(s)
Giles, W. R., & Noble, D. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2015.06.070 · Cited by 23
Goodrow, R. J., Desai, S., Treat, J. A., Panama, B. K., Desai, M., Nesterenko, V. V., & Cordeiro, J. M. (2017) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2017.11.001 · Cited by 24
Hodgson, P., Ireland, J., & Grunow, B. (2018) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2018.04.009 · Cited by 23
Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Rampoldi, A., Singh, M., Wu, Q., Duan, M., Jha, R., Maxwell, J. T., Bradner, J. M., Zhang, X., Saraf, A. P., Miller, G. W., et al. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz038 · Cited by 25
Medicinal Biotechnology for Disease Modeling, Clinical Therapy, and Drug Discovery and Development
Duelen, R., Corvelyn, M., Tortorella, I., Leonardi, L., Chai, Y. C., & Sampaolesi, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-22141-6_5 · Cited by 29
Jeziorowska, D., Korniat, A., Salem, J., Fish, K. M., & Hulot, J. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1064109 · Cited by 24
Dorn, C., Grunert, M., & Sperling, S. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/elt040 · Cited by 26
Early Repolarization Syndrome; Mechanistic Theories and Clinical Correlates
Mercer, B. N., Begg, G. A., Page, S. P., Bennett, C., Tayebjee, M. H., & Mahida, S. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00266 · Cited by 24
Chen, L., He, Y., Wang, X., Ge, J., & Li, H. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.530 · Cited by 23
Precision medicine for long QT syndrome: patient-specific iPSCs take the lead
Yu, Y., Deschênes, I., & Zhao, M. (2023) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.43 · Cited by 24
Clancy, C. E., & Santana, L. F. (2024) · The Journal of Physiology · doi:10.1113/jp282562 · Cited by 25
Liu, Q., & Trudeau, M. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123951 · Cited by 22
Perspectives of induced pluripotent stem cells for cardiovascular system regeneration
Csöbönyeiová, M., Polák, Š., & Danišovič, Ľ. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370214565976 · Cited by 22
Pan, Z., Ebert, A., & Liang, P. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02486-y · Cited by 22
Paci, M., Casini, S., Bellin, M., Hyttinen, J., & Severi, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113583 · Cited by 22
Self-citationKane, C., Du, D. T. M., Hellen, N., & Terracciano, C. M. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2015.08.052 · Cited by 22
Dowaidar, M. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/3nwzd · Cited by 26
Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges
Seah, S., Farran, C. A. E., Warrier, T., Xu, J., & Loh, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226119 · Cited by 26
Giacomelli, E., Sala, L., Oostwaard, D. W., & Bellin, M. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.07.068 · Cited by 23
Self-citationNovel CALM3 Variant Causing Calmodulinopathy With Variable Expressivity in a 4-Generation Family
Kato, K., Isbell, H. M., Fressart, V., Denjoy, I., Debbiche, A., Itoh, H., Poinsot, J., George, A. L., Coulombe, A., Shea, M. A., et al. (2022) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.121.010572 · Cited by 23
Cell-based therapies for the preterm infant
Zhu, D., Wallace, E. M., & Lim, R. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.06.004 · Cited by 21
The Future of Induced Pluripotent Stem Cells for Cardiac Therapy and Drug Development
Thorrez, L., & Sampaolesi, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797904154 · Cited by 24
Vyas, B., Puri, R. D., Namboodiri, N., Nair, M., Sharma, D., Movva, S., Saxena, R., Bohora, S., Aggarwal, N., Vora, A. M., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37636 · Cited by 21
Preininger, M. K., Singh, M., & Xu, C. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-45457-3_10 · Cited by 22
Gélinas, R., Khoury, N. E., Chaix, M., Beauchamp, C., Alikashani, A., Éthier, N., Boucher, G., Villeneuve, L. R., Robb, L. J., Latour, F., et al. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.117.001755 · Cited by 21
Bekhite, M. M., & Schulze, P. C. (2021) · Cells · doi:10.3390/cells10123483 · Cited by 25
Kamdar, F. D., Kamdar, A. K., Koyano‐Nakagawa, N., Garry, M. G., & Garry, D. J. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.04.010 · Cited by 22
Orban, M. W., Goedel, A., Haas, J., Sandrock-Lang, K., Gärtner, F., Jung, C. B., Zieger, B., Parrotta, E. I., Kurnik, K., Sinnecker, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115978 · Cited by 24
Self-citationHuang, H., Chuang, C.-Y., & Kuo, H. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt125 · Cited by 23
Kidney bioengineering in regenerative medicine: An emerging therapy for kidney disease
Lin, Y.-Q., Wang, L., Pan, L., Wang, H., Zhu, G., Liu, W., Wang, J., Braddock, M., & Zheng, M. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.10.004 · Cited by 23
Calcium and voltage mapping in hiPSC-CM monolayers
Herron, T. J. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.02.004 · Cited by 24
Young, W. (2012) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.s10-010 · Cited by 24
Schwan, J., & Campbell, S. G. (2015) · Biomarker Insights · doi:10.4137/bmi.s23912 · Cited by 23
Concise Review: The Magic Act of Generating Induced Pluripotent Stem Cells: Many Rabbits in the Hat
Mostoslavsky, G. (2011) · Stem Cells · doi:10.1002/stem.742 · Cited by 23
Metadata
- Authors
- Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., Seyfarth, M., Sinnecker, D., Schömig, A., & Laugwitz, K.-L.
- Affiliations
- TUM Klinikum (DE)
- Deutsches Herzzentrum München (DE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1397-1409
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2104996733
- Cited by
- 1,251
- References
- 40
- Citations by year
- 2026: 26 · 2025: 26 · 2024: 43 · 2023: 49 · 2022: 51 · 2021: 79 · 2020: 56 · 2019: 69 · 2018: 69 · 2017: 89 · 2016: 90 · 2015: 111 · 2014: 90 · 2013: 116 · 2012: 143
- FWCI
- 88.47
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- LQT1, KCNQ1, induced pluripotent stem cells, patient-specific disease models, cardiomyocyte differentiation, action potential prolongation, delayed rectifier potassium current, beta-adrenergic blockade, sudden cardiac death, ventricular repolarization
- MeSH terms
- Kruppel-Like Factor 4, Action Potentials, Adrenergic beta-Antagonists, Adult, Aged, Cardiotonic Agents, Child, Female, Fibroblasts, Humans, Isoproterenol, Male, Pedigree, Phenotype, Potassium Channels, Gene Expression, Mutation, Missense, Reverse Transcriptase Polymerase Chain Reaction, Potassium Channel Blockers, Romano-Ward Syndrome, Myocytes, Cardiac, KCNQ1 Potassium Channel, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.